⌘K

Login Start Free

Home/Filings/4/0001181431-10-044676

4//SEC Filing

MARTIN J TYLER 4

Accession 0001181431-10-044676

CIK 0001029142other

View on SEC.gov Company Profile

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 5:33 PM ET

Size

5.7 KB

Accession

0001181431-10-044676

Insider Transaction Report

Form 4

Period: 2010-08-25

DYNAVAX TECHNOLOGIES CORPDVAX

VP Clinical Development & CMO

Transactions

Award
Option (Right to Buy)
2010-08-25+517,244→ 517,244 total
Exercise: $1.72Exp: 2020-08-24→ Common Stock (517,244 underlying)

Footnotes (2)

[F1]This option grant shall vest in equal annual installments over four years from August 25,2010.
[F2]Not applicable.

Documents

1 file

4
rrd285100.xmlPrimary
FORM 4

Issuer

DYNAVAX TECHNOLOGIES CORP

CIK 0001029142

Entity typeother

Related Parties

1

filerCIK 0001234388

Filing Metadata

Form type: 4
Filed: Aug 26, 8:00 PM ET
Accepted: Aug 27, 5:33 PM ET
Size: 5.7 KB

View on SEC.gov